INM
InMed Pharmaceuticals Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website inmedpharma.com
- Employees(FY) 13
- ISIN CA4576376012
Performance
+7.51%
1W
-3.44%
1M
-14.02%
3M
-26.0%
6M
-29.11%
YTD
-74.36%
1Y
Profile
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products. The company operates through two segments, the InMed and the BayMedica. The InMed segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with high unmet medical needs. The company's lead product is INM-755, a cannabinol topical skin cream, completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-900 for neurodegenerative diseases. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach, for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
Technical Analysis of INM 2024-05-10
Overview:
In analyzing the technical indicators for the stock of INM over the last 5 days, we will delve into the trends, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and recommendations ...
Recent News & Updates
- 2023-03-12 19:30
- 2023-03-09 19:35
- 2023-03-06 19:35
- 2023-03-06 18:00
- 2023-03-06 05:00
InMed to Participate in Upcoming Investor Events(Yahoo Finance)
- 2023-02-17 04:00
- 2023-02-09 08:41
InMed Submits Form 12b-25(Yahoo Finance)
- 2023-01-09 18:30
InMed Provides Business Update and Milestones for 2023(Yahoo Finance)
- 2022-12-15 05:17
InMed Announces Results of 2022 Annual General Meeting(Yahoo Finance)
- 2022-12-12 05:47
- 2022-11-22 23:18
- 2022-11-21 04:00
- 2022-11-17 19:00
- 2022-11-16 21:32
- 2022-11-16 18:30
InMed Provides Update on Management Changes(Yahoo Finance)
- 2022-11-15 23:13
- 2022-11-15 18:00
- 2022-11-11 05:51
- 2022-11-09 18:30
- 2022-10-25 19:30
- 2022-10-23 22:13
10 Best Pharma Stocks To Buy Now(Yahoo Finance)
- 2022-09-23 00:29
- 2022-09-19 06:00
- 2022-09-13 05:12
- 2022-09-09 05:00
- 2022-09-08 02:08
- 2022-08-23 05:00
- 2022-08-08 19:30
InMed Announces Changes to its Board of Directors(Yahoo Finance)
- 2022-07-24 19:30
- 2022-07-17 19:30
InMed Announces Appointment of Chief Operating Officer(Yahoo Finance)